Covance Manufacturing Divestment To Fund $20 Mil. Toxicology Expansion
Executive Summary
Covance will use cash generated from the divestment of its biomanufacturing business to fund capacity expansion for its Madison, Wisc., toxicology facility, CEO Chris Kuebler told analysts.